Register Login

PHARVARIS N.V. (PHVS)

Lesage Anne 🟡 adjusted position in 48.3K shares (3 derivative) of Pharvaris N.V. (PHVS) at $30.26 ($1.8M) Transaction Date: Apr 29, 2026 | Filing ID: 201925

Full text
Register to leave comments
  • News bot May 1, 2026, 11:31 p.m.

    🔍 Lesage Anne (Executive)

    Company: Pharvaris N.V. (PHVS)

    Report Date: 2026-04-29

    Transaction Summary:

    • Total transactions: 11
    • Derivative instruments: 3
    • Holdings reported: 0
    • Total shares acquired: 25,400
    • Total shares sold: 73,700

    Detailed Transactions and Holdings:

    • Acquired 3,700 shares of Common Stock at $2.59 per share (Direct)
      Date: 2026-04-29 | Code: M | equity_swap_involved: false | shares_owned_after: 60,150.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,700 shares of Common Stock at $30.0758 per share (Direct)
      Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 56,450.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 3,700 shares of Common Stock at $2.59 per share (Direct)
      Date: 2026-04-30 | Code: M | equity_swap_involved: false | shares_owned_after: 60,150.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,700 shares of Common Stock at $30.2558 per share (Direct)
      Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 56,450.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 18,000 shares of Common Stock at $8.05 per share (Direct)
      Date: 2026-04-30 | Code: M | equity_swap_involved: false | shares_owned_after: 74,450.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 18,000 shares of Common Stock at $30.2558 per share (Direct)
      Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 56,450.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,700 shares of Common Stock at $30.062 per share (Direct)
      Date: 2026-04-29 | Code: S | equity_swap_involved: false | shares_owned_after: 153,169.00 | transaction_form_type: 4 | Footnotes: F3, F2, F4
    • Sold 19,200 shares of Common Stock at $30.2557 per share (Direct)
      Date: 2026-04-30 | Code: S | equity_swap_involved: false | shares_owned_after: 133,969.00 | transaction_form_type: 4 | Footnotes: F3, F5, F4
    • Sold 3,700 shares of Stock Option (Right to Buy) at $2.59 per share (Derivative)
      Date: 2026-04-29 | Code: M | Expires: 2030-01-01 | equity_swap_involved: false | shares_owned_after: 12,772.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Sold 3,700 shares of Stock Option (Right to Buy) at $2.59 per share (Derivative)
      Date: 2026-04-30 | Code: M | Expires: 2030-01-01 | equity_swap_involved: false | shares_owned_after: 9,072.00 | transaction_form_type: 4 | Footnotes: F1, F6
    • Sold 18,000 shares of Stock Option (Right to Buy) at $8.05 per share (Derivative)
      Date: 2026-04-30 | Code: M | Expires: 2033-04-06 | equity_swap_involved: false | shares_owned_after: 82,000.00 | transaction_form_type: 4 | Footnotes: F1, F7

    Footnotes:

    • F1: This is a scheduled exercise and sale from 10b5-1 trading plan.
    • F2: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $30.00 to $30.20. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
    • F3: This is a scheduled sale from 10b5-1 trading plan.
    • F4: GrayMatters Consulting B.V., an entity controlled by Dr. Lesage
    • F5: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date pursuant to a Rule 10b5-1 trading plan. The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. The sales prices for the transactions ranged from $30.00 to $30.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
    • F6: 25% of the option vested on January 1, 2021 with the remaining shares vesting in 1/48 monthly installments thereafter.
    • F7: 25% of the option vested on April 6, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.

Search

News categories